Merck & Co Inc
Merck beats on revenue boosted by Keytruda sales, but posts quarterly loss due to Prometheus deal
Merck on Tuesday reported second-quarter revenue that topped expectations on strong sales of its blockbuster cancer drug Keytruda and HPV vaccine Gardasil. The pharmaceutical giant posted a quarterly loss, however, due to charges associated with the company’s acquisition of Prometheus Biosciences earlier this year. related investing news Merck swung to a net loss of $5.98 […]
Read More
Inventory futures are minimal adjusted as Wall Street’s busiest earnings 7 days carries on: Stay updates
Traders operate on the floor of the New York Inventory Exchange, July 12, 2023. Spencer Platt | Getty Visuals U.S. stock futures traded close to the flat line Monday night as traders await a flood of company earnings stories. Dow Jones Industrial Ordinary futures rose by 12 points, or .03%. Futures joined to the S&P […]
Read More
Earnings playbook: How to trade some of the greatest reports this week, including Apple
This could be a make-or-break 7 days for next-quarter earnings year. When all is mentioned and accomplished, about 160 S & P 500 businesses will have claimed their latest quarterly outcomes — making this the busiest 7 days of the overall reporting interval. By Monday’s open, more than 250 names experienced previously documented, with 81% […]
Read More
A.I. could mean a ‘decade of health care is upon us.’ Here are some stock picks
Investors hoping to capture more upside from artificial intelligence could turn to a sector that’s underperformed this year, and maybe not immediately associated with AI: Health care. A handful of large tech names surged in the first half thanks to a mania for all things tied to artificial intelligence. Apple, for example, last week closed […]
Read More
Moderna strikes deal to develop mRNA drugs in China
Nikos Pekiaridis | Nurphoto | Getty Images Moderna on Wednesday said it struck a deal with Chinese officials to research, develop and manufacture messenger RNA medicines in the country, despite rising tensions between the U.S. and China. The Massachusetts-based biotech company signed a memorandum of understanding and a related land collaboration deal to develop drugs […]
Read More
Medicare will allow pharmaceutical companies to publicly discuss drug price negotiations
Hundreds of 1199SEIU health care workers staged a rally and sit to block 3rd avenue where some were arrested. They protested against health care cuts in Governor Kathy Hochuls budget on Medicare. Lev Radin | Lightrocket | Getty Images Medicare on Friday said it will allow pharmaceutical companies to publicly discuss the program’s historic drug […]
Read More
Pharmaceutical trade group sues Biden administration over Medicare drug price negotiations
Traders work on the floor of the New York Stock Exchange during morning trading, April 10, 2023. Michael M. Santiago | Getty Images The pharmaceutical industry’s largest lobbying group and two other organizations on Wednesday sued the Biden Administration over Medicare’s new powers to slash drug prices for seniors under the Inflation Reduction Act. Pharmaceutical […]
Read More
Drugmakers aim to strike down Medicare drug-price negotiations at Supreme Court
Chief Executive Officers of pharmaceutical companies testify before the Senate Finance Committee on “Drug Pricing in America: A Prescription for Change, Part II” February 26, 2019 in Washington, DC. From left to right are Richard A. Gonzalez, chairman and CEO of AbbVie Inc; Pascal Soriot, executive director and CEO of AstraZeneca; Giovanni Caforio, chairman of […]
Read More
Inventory futures are flat soon after S&P 500 notches best near considering the fact that August: Stay updates
A trader is effective on the flooring of the New York Stock Trade (NYSE) in New York Metropolis, U.S., May possibly 30, 2023. Brendan McDermid | Reuters Shares futures had been flat in overnight investing after the S&P 500 notched its highest closing stage of 2023. The tail-end of earnings year pressed on with benefits […]
Read More
Merck sues Biden administration over Medicare drug price negotiations
Jakub Porzycki | NurPhoto | Getty Images Global drugmaker Merck on Tuesday sued the Biden administration over Medicare’s new powers to substantially reduce drug prices for seniors under the Inflation Reduction Act, the opening salvo in the pharmaceutical industry’s efforts to weaken the program. In a scathing complaint filed in federal district court, Merck excoriated […]
Read More